SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett(MRC University of Glasgow Centre for Virus Research), James Austin(University of Liverpool), William T. Harvey(MRC University of Glasgow Centre for Virus Research), Kathryn Puxty(NHS Greater Glasgow and Clyde), Oscar A. MacLean(MRC University of Glasgow Centre for Virus Research), Rory Gunson(NHS Greater Glasgow and Clyde), Diego Cantoni(Medway School of Pharmacy), Christopher Davis(California University of Pennsylvania), Elen Vink(MRC University of Glasgow Centre for Virus Research), Shirin Ashraf(MRC University of Glasgow Centre for Virus Research), Joe Grove(MRC University of Glasgow Centre for Virus Research), Joseph Hughes(MRC University of Glasgow Centre for Virus Research), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Giuditta De Lorenzo(MRC University of Glasgow Centre for Virus Research), Wilhelm Furnon(MRC University of Glasgow Centre for Virus Research), Rute Maria Pinto(Roslin Institute), Sam M. Murray(University of Oxford), Vanessa Silva(University of Lisbon), Maria Manali(MRC University of Glasgow Centre for Virus Research), Matthew T. G. Holden(Wellcome Sanger Institute), Craig Wilkie(University of Glasgow), Nicola Logan(MRC University of Glasgow Centre for Virus Research), Arvind H. Patel(MRC University of Glasgow Centre for Virus Research), Thushan I. de Silva(Sheffield Teaching Hospitals NHS Foundation Trust), David J. Pascall(University of Cambridge), L. Tong(MRC University of Glasgow Centre for Virus Research), Alexandra Deeks(University of Oxford), Ana da Silva Filipe(MRC University of Glasgow Centre for Virus Research), Sam Scott(MRC University of Glasgow Centre for Virus Research), Katherine Smollett(MRC University of Glasgow Centre for Virus Research), Barbara Kronsteiner(Angkor Hospital for Children), Kate Templeton(NHS Lothian), Sandra Adele(Medawar Building for Pathogen Research), Poppy Holland(NHS Greater Glasgow and Clyde), Susanna Dunachie(Mahidol University), Richard Orton(MRC University of Glasgow Centre for Virus Research), M. Azim Ansari(Centre for Human Genetics), Agnieszka M. Szemiel(MRC University of Glasgow Centre for Virus Research), Sharif Shaaban(Public Health Scotland), Patawee Asamaphan(MRC University of Glasgow Centre for Virus Research), Shona C. Moore(University of Liverpool), Pablo R. Murcia(MRC University of Glasgow Centre for Virus Research), Lance Turtle(University of Liverpool), Vanessa M. Cowton(MRC University of Glasgow Centre for Virus Research), Priyanka Abraham(University of Oxford), Gonzalo Yebra(Public Health Scotland), Anthony Brown(University of Oxford)
Cited by 724
Related Papers
Roary: rapid large-scale prokaryote pan genome analysis
|Bioinformatics|2015|5.9k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k